FDA Drugs recall ·
Dihydroergotamine Mesylate Injection, solution for injection, USP… recall
- Recall number
- D-0150-2025
- Date
- (initiated November 22, 2024)
- Company / brand
- Provepharm Inc.
100 Springhouse Dr Ste 105, Collegeville, PA, United States - Category
- Drugs › Class II
- Classification
- Class II
- Status
- Ongoing
- Units affected
- 2160 packs/5 ampules per pack = 10,800 ampules
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05
Why was it recalled?
Discoloration
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot #: F9026F01, F9026F02, Exp. Date 12/2025
Distribution
Nationwide within the United States
What does Class II mean?
Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.
Source: FDA (drugs), recall D-0150-2025. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.